12/1
09:06 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $19.00 price target on the stock.
High
Report
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $19.00 price target on the stock.
12/1
08:56 am
lxeo
Rating for LXEO
High
Report
Rating for LXEO
11/20
08:28 am
lxeo
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
Medium
Report
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
11/20
08:07 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $19.00 price target on the stock.
Medium
Report
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $19.00 price target on the stock.
11/20
06:56 am
lxeo
Rating for LXEO
Medium
Report
Rating for LXEO
11/20
06:06 am
lxeo
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
Medium
Report
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
11/5
07:19 pm
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $17.00 price target on the stock.
Low
Report
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $17.00 price target on the stock.
11/5
07:15 pm
lxeo
Rating for LXEO
Low
Report
Rating for LXEO
11/3
01:09 pm
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/17
05:44 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
High
Report
Lexeo Therapeutics (NASDAQ:LXEO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
10/17
05:44 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
High
Report
Lexeo Therapeutics (NASDAQ:LXEO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
10/15
10:24 am
lxeo
Rating for LXEO
Low
Report
Rating for LXEO
10/15
10:24 am
lxeo
Rating for LXEO
Low
Report
Rating for LXEO
10/15
07:23 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Low
Report
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
10/15
07:23 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Low
Report
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
10/15
06:24 am
lxeo
Lexeo Therapeutics initiated with a Buy at Guggenheim
Low
Report
Lexeo Therapeutics initiated with a Buy at Guggenheim
10/15
06:24 am
lxeo
Lexeo Therapeutics initiated with a Buy at Guggenheim
Low
Report
Lexeo Therapeutics initiated with a Buy at Guggenheim
10/7
01:55 pm
lxeo
Rating for LXEO
Low
Report
Rating for LXEO
10/7
01:02 pm
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/7
11:19 am
lxeo
Rating for LXEO
Low
Report
Rating for LXEO